The Australian Immunity
(AIM) Trial
Outside the box thinking to deliver a remote research study for The a2 Milk Company
iDENTIFY the issue
Social distancing, quarantine, vaccination, delayed subject enrolment, and data collection were all impacted during the COVID-19 pandemic. How could we still deliver a clinical trial with scientific integrity and quality during this time?
iNVESTIGATE the opportunity
Our team investigated and pioneered a randomised controlled study design that was fully remote and virtual with food provision and pathology collection that was scientifically robust.
iMPLEMENT solutions
We designed the 100% remote Australian Immunity Trial, which assessed the effects of a2 milk on immunity and inflammation. A randomised crossover clinical trial which included a run-in period, a washout period, and two intervention periods, with data collection including four blood samples collected across the intervention and 100% of food provision.
The iMPACT we created
Rapid recruitment: Target of 100 participants was met within two months of launching study.
High participant retention rate: 88% of participants that commenced the first intervention period completed the study.
Proactive problem solving: The remote study design required an agile and responsive research team.
We use our iQ³ process to identify a food nutrition issue or problem, investigate opportunities, and implement the optimal solution with scale and impact for companies, organisations, healthcare professionals, and consumers.
Have a project that could benefit from our iQ³ process?
Contact FOODiQ Global today.
Join us on this journey as we unlock the potential of food and nutrition science to transform lives and contribute to a healthier world for all.
